Isis Pharmaceuticals, Inc. Requests that the marked portions of the exhibit be granted confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934.Isis Pharmaceuticals Inc • November 6th, 2012 • Pharmaceutical preparations
Company FiledNovember 6th, 2012 Industry